DarioHealth (DRIO) Invested Capital (2021 - 2026)

DarioHealth (DRIO) has reported Invested Capital for 6 consecutive years, with $86.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital fell 8.82% year-over-year to $86.2 million; the trailing twelve-month figure through Jun 2026 stood at $86.2 million (down 8.82% YoY), and the FY2025 full-year result was $98.7 million, down 2.25% from the prior year.
• Invested Capital declined to $86.2 million in Q2 2026 per DRIO's latest filing, from $93.3 million in the prior quarter.
• Across five years, Invested Capital topped out at $124.5 million in Q2 2022 and bottomed at $86.2 million in Q2 2026.
• Historically, Invested Capital has averaged $101.2 million across 5 years, with a median of $99.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Invested Capital gained 24.99% in 2022, then dropped 18.93% in 2023.
• Over 5 years, Invested Capital stood at $106.9 million in 2022, then slipped by 18.93% to $86.7 million in 2023, then grew by 16.44% to $100.9 million in 2024, then dropped by 2.25% to $98.7 million in 2025, then fell by 12.69% to $86.2 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $86.2 million, $93.3 million, and $98.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.